Pro Medicus (Pro Medicus) YoY EBITDA Growth : 29.17% (As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is Pro Medicus YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Pro Medicus's YoY EBITDA Growth for the quarter that ended in Dec. 2023 was 29.17%.

Pro Medicus's EBITDA per Share for the six months ended in Dec. 2023 was $0.34.

Pro Medicus YoY EBITDA Growth Historical Data

The historical data trend for Pro Medicus's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pro Medicus YoY EBITDA Growth Chart

Pro Medicus Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

YoY EBITDA Growth

Get a 7-Day Free Trial

33.97

19.14

45.38

29.28

25.64

Pro Medicus Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
YoY EBITDA Growth	Get a 7-Day Free Trial															36.25	26.50	21.10	28.85	29.17

Pro Medicus YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Pro Medicus's YoY EBITDA Growth for the fiscal year that ended in Jun. 2023 is calculated as:

	YoY EBITDA Growth (A: Jun. 2023 )
=	(EBITDA per Share (A: Jun. 2023 )	-	EBITDA per Share (A: Jun. 2022 ))	/	\| EBITDA per Share (A: Jun. 2022 ) \|
=	(0.588	-	0.468)	/	\| 0.468 \|
=	25.64 %

Pro Medicus's YoY EBITDA Growth for the quarter that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (Q: Dec. 2023 )
=	(EBITDA per Share (Q: Dec. 2023 )	-	EBITDA per Share (Q: Dec. 2022 ))	/	\| EBITDA per Share (Q: Dec. 2022 )) \|
=	(0.341	-	0.264)	/	\| 0.264 \|
=	29.17 %

Pro Medicus YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Pro Medicus's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Pro Medicus (Pro Medicus) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Pro Medicus Ltd (OTCPK:PMCUF) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

PMC:Germany PME:Australia

Address

450 Swan Street, Richmond, Melbourne, VIC, AUS, 3121

Website

https://www.promed.com.au

Pro Medicus is a healthcare IT company specializing in radiology imaging software. Its main product, Visage 7, is a clinical desktop application that radiologists use to view, enhance, and manipulate images from any device and make a diagnosis. Its main customers are U.S. private academic hospitals. In fiscal 2022, Pro Medicus earned 79% of revenue in North America, 16% from Australia, and the remaining 6% in Europe.